NightHawk Biosciences, Inc. (NHWK)の価格はいくらですか

NightHawk Biosciences, Inc. (NHWK)の価格は$0.3136です

NightHawk Biosciences, Inc. (NHWK)の時価総額は何ですか

NightHawk Biosciences, Inc. (NHWK)の時価総額は$7.97Mです

NightHawk Biosciences, Inc.（NHWK）PER（株価収益率）

NightHawk Biosciences, Inc. operates as an integrated biopharmaceutical firm, dedicated to advancing immune therapies and vaccines. Their core mission involves leveraging and modifying the body's immune system to combat a range of illnesses, particularly various cancers and infectious diseases. Central to their strategy is the proprietary gp96 platform. This platform encompasses two key technologies: ImPACT, an allogeneic (off-the-shelf) cell-based system designed to activate and expand T-cells, acting as a broad immune stimulant; and ComPACT, which combines antigen-specific T-cell activation with targeted co-stimulation in a single product. NightHawk's clinical pipeline features several promising candidates: HS-110, which has completed enrollment for its Phase II clinical trial, targeting advanced non-small cell lung cancer; and HS-130, currently undergoing a Phase I clinical trial for advanced solid tumors. Additionally, PTX-35, a novel T-cell co-stimulator agonist antibody that specifically targets DR3/TNFRSF25, is also in Phase I development. The company is also exploring DR3/TNFRSF25 as a general target for various immunotherapy applications. Beyond these, a COVID-19 vaccine is currently in preclinical stages. A notable collaboration involves Dr. James Shapiro at the University of Alberta, focusing on the manufacturing of a surrogate mouse version of PTX-35. Originally established as Heat Biologics, Inc. in 2008, the company rebranded to NightHawk Biosciences, Inc. in May 2022. Its headquarters are located in Morrisville, North Carolina.

年	P/E比率	変化
提供された日付のデータは十分ではありません。

年

P/E比率

変化

提供された日付のデータは十分ではありません。

企業	P/E比率	P/E比率の差	国
Vertex Pharmaceuticals Incorporated VRTX.US	29.20	-	US
Argenx SE ARGX.US	30.62	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	18.38	-	BE

企業

P/E比率

P/E比率の差

国